AndreaBozzo/ceres-open-data-index huggingface dataset:
CCWIS Technical Bulletin #5

This Technical Bulletin (TB) provides title IV-E agencies with information regarding the process for allocating CCWIS project costs and the associated federal financial participation (FFP) funding implications. Understanding the cost allocation requirements and their impact on funding may influence how title IV-E agencies plan, design, develop, implement, and operate their CCWIS. This guidance is not applicable to a title IV-E agency that is developing or operating a non-CCWIS application.

Metadata-only record linking to the original dataset. Open original dataset below.
Title IV-E Programs Expenditure and Caseload Data 2022

The Children’s Bureau posts an annual FY summary of Form CB-496 expenditures and caseloads as reported by each title IV-E agency. These data tables include the combination of current-quarter and prior-quarter adjustment expenditures and current-quarter caseload data as delineated in quarterly Form CB-496 submissions for FY 2022.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525094: 1,3-Dichloroisopropyl butyrate

Chemical compound data from PubChem database. IUPAC Name: 1,2-dichloropropan-2-yl butanoate. Molecular Formula: C7H12Cl2O2. Molecular Weight: 199.07. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2008 Directory of U.S. Mental Health Facilities

This publication is a national directory of mental health treatment facilities for 2008. This directory lists federal, state, and local government facilities and private facilities that provide mental health treatment services. The information about each facility that appears in this directory was provided by that facility in response to the 2008 National Mental Health Services Survey (N-MHSS). The Substance Abuse and Mental Health Services Administration (SAMHSA) conducts the N-MHSS annually. The directory is ordered alphabetically by state, by city within each state, and by facility name within each city. This directory includes mental health treatment facilities for all U.S. states and territories.
National Directory of Drug and Alcohol Abuse Treatment Facilities - 1990

The National Directory of Drug and Alcohol Abuse Treatment Programs 1990 lists federal, state, local, and private facilities that provide substance abuse treatment services. The directory includes treatment facilities that are licensed, certified, or otherwise approved for inclusion in the directory by their state substance abuse agencies and that responded to the 1989 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this directory was provided by that facility in response to the 1989 N-SSATS. The Substance Abuse and Mental Health Services Administration (SAMHSA) conducts the N-SSATS annually.
MD iMAP: Maryland Community Health Resource Commission - Childhood Obesity Grantees

This is a MD iMAP hosted service. Find more information at  http://imap.maryland.gov. Childhood Obesity Grantees - The Maryland Community Health Resources Commission works to expand access to health care services for low-income and under-served communities across the state.Feature Service Link:http://geodata.md.gov/imap/rest/services/Health/MD_CommunityHealthResourceCommission/FeatureServer/1 ADDITIONAL LICENSE TERMS: The Spatial Data and the information therein (collectively "the Data") is provided "as is" without warranty of any kind either expressed implied or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct indirect incidental consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Compound 526954: 2,2,4,6,8,10-Hexamethyl-4,6,8,10-tetraphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane

Chemical compound data from PubChem database. IUPAC Name: 2,2,4,6,8,10-hexamethyl-4,6,8,10-tetraphenyl-1,3,5,7,9,2,4,6,8,10-pentaoxapentasilecane. Molecular Formula: C30H38O5Si5. Molecular Weight: 619.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Florida Study of Professional for Safe Families (FSPSF), Waves 1-8

The Florida Study of Professionals for Safe Families (FSPSF) is a longitudinal study of Florida’s 
child welfare workforce. The primary focus of the study examines turnover and retention 
decisions among frontline workers. FSPSF project staff recruited all Child Protective 
Investigators and Dependency Case Managers in pre-service training between Sept. 1, 2015 and 
December 31, 2016 and 84% of eligible participants provided consent and baseline information 
(N = 1,500). Participants were followed during the study timeframe even if they left their child 
welfare positions. Workers were surveyed every six months for approximately 3.5 years 
focusing on individual, occupational, and organizational influences on child welfare employee 
retention. 
This statewide study examined worker personal characteristics (e.g., educational background, 
family history, self-esteem, etc.) worker experiences and responses (e.g., stress and burnout, 
work/family balance, social support, and coping, etc.), and organizational influences (e.g., 
organizational climate, supervisory practices, and caseload responsibilities etc.). Respondents 
were surveyed every 6-7 months with a core instrument and three in-depth substantive modules 
that were rotated during the data collection period. Modules included a focus on 
(1) supervision and organizational functioning (assessed at waves 2, 5, and 8); 
(2) work/family life balance (assessed at waves 3, 6 and 8); and 
(3) mental health (assessed at waves 4 and 7). 
Overall, 100% of child welfare administrative units across the state of Florida agreed to be part 
of the study. Individual response rates for each wave were also very high. Across all waves of 
data collection, response rates averaged 81% and ranged from 77% to 87%, and 62% (n = 929) 
of participants responded at every wave of data collection.


Documentation for the data includes:

Investigators: Dina J. Wilke, PhD, MSW
Florida State University Tallahassee, FL

Melissa Radey, PhD, MSSW, MA
Florida State University Tallahassee, FL

Lisa Magruder, PhD, MSW
Florida State University Tallahassee, FL
Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 1 - Boston

Rate of deaths by age/gender (per 100,000 population) for people killed in crashes involving a driver with BAC =>0.08%, 2012, 2014. 2012 Source: Fatality Analysis Reporting System (FARS). 2014 Source: National Highway Traffic Administration's (NHTSA) Fatality Analysis Reporting System (FARS), 2014 Annual Report File. Note: Blank cells indicate data are suppressed. Fatality rates based on fewer than 20 deaths are suppressed.
Compound 525219: Chloromethyl 6-chloro-octanoate

Chemical compound data from PubChem database. IUPAC Name: chloromethyl 6-chlorooctanoate. Molecular Formula: C9H16Cl2O2. Molecular Weight: 227.12. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40115-T1: [Translated] TETRAHYDRO-BENZO (E) ISOINDOLINE.

Disclosed herein are tetrahydro-benzo [e] isoindolines useful in the treatment of hypertension, which are represented by the formula <CHEM> wherein R, R1, and R2 are independently selected from hydrogen, hydroxy, loweralkoxy of 1 to 3 carbon atoms, loweralkenyloxy of 1 to 3 carbon atoms, benzyloxy, benzoyloxy, thiomethyl, halo, or <CHEM> wherein R4 and R5 are independently selected from hydrogen, loweracyl of 1 to 4 carbon atoms or sulfonyl of the formula <CHEM> wherein R6 is loweralkyl of 1 to 4 carbon atoms; or R and R1, or R1 and R2 can be taken together to form a methylenedioxy or ethylenedioxy bridge; with the proviso that at least one of R, R1 or R2 must be other than hydrogen; and R3 is hydrogen; loweralkyl of 1 to 4 carbon atoms; halo-substituted loweralkyl of 1 to 4 carbon atoms; arylalkyl of the formula <CHEM> wherein m is 0, 1 or 2, p is 0 or 1, R7 is hydrogen or loweralkyl of 1 to 4 carbon atoms and R8 and R9 are independently selected from hydrogen, hydroxy, methoxy, loweralkyl of 1 to 4 carbon atoms, or halo, or R8 and R9 can be taken together to form a methylendioxy or ethylenedioxy bridge; or 1,4-benzodioxan.
National Survey of Substance Abuse Treatment Services (N-SSATS): 2009 Data on Substance Abuse Treatment Facilities

This report presents results from the 2009 National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 states, the District of Columbia, and other U.S. jurisdictions.
2013 CMHS Uniform Reporting System (URS) Table for North Carolina

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for North Carolina for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Physico-chemical characterisation and biological evaluation of 188-Rhenium colloids for radiosynovectomy

Background
          Radiosynovectomy is a type of radiotherapy used to relieve pain and inflammation from rheumatoid arthritis. In this study, 188-Rhenium (188Re) colloids were characterized by physical and biological methodologies. This was used to assess which parameters of the kit formulation would be the basis in the development of a more effective radiopharmaceutical for synovectomy. Intraarticular injection in knees of rabbits assessed cavity leakage of activity.
        
        
          Methods
          The physical characteristics of tin (Sn) and sulphur (S) colloids were determined to assess the formulation with suitable properties. Particles were grouped in three ranges for analyzing their distribution according to their number, volume and surface. The ideal particle size range was considered to be from 2 to 10 microns. Membrane filtration and laser diffraction characterization methodologies were used.
        
        
          Results
          While membrane filtration could give misleading data, laser diffraction proportions more reliable results. The Sn colloid showed a better distribution of particle volume and surface than S colloid, in the 2 to 10 microns range. The 188Re-Sn colloid was obtained with a radiochemical purity higher than 95% after 30 minutes of autoclaving. While Sn colloid kit stability was verified for 60 days, the 188Re-Sn preparation was stable in the first 24 hrs. No significant intrabatch variability (n = 3) was detected. Biodistribution and scintigraphic studies in rabbits after intraarticular injection showed relevant activity only in knee, being 90% at 48 hours.
        
        
          Conclusion
          The 188Re-Sn colloid is easy to prepare, is stable for 24 hours and shows minimal cavity leakage after intraarticular injection into rabbit knees, suggesting this radiotherapeutical agent has suitable physical properties for evaluation for joint treatment in humans.
SuperTracker - source code and foods database

SuperTracker was an online tool offered by USDA (2011-2018) that helped users track diet, physical activity and weight. SuperTracker provided a personalized plan based on the 2015-2020 Dietary Guidelines for Americans for what you should eat and drink and guided users to making better choices.  This dataset includes the SuperTracker source code (latest update April 2018), including: front end application, database schema, documentation, deployment scripts and a ReadMe.txt file that provides high level instructions for the source code. Database connection strings and actual data are not included. The full foods database spreadsheet is attached as well; these foods are based on the Food and Nutrient Database for Dietary Studies (FNDDS), and the Food Patterns Equivalents Database (FPED), both from the USDA/ARS Food Surveys Research Group.

It is important to note that the code is based on 2015-2020 Dietary Guidelines for Americans and will not be updated to reflect future guidance. In addition, the food database is based on FNDDS from 2011-2012 (FNDDS 6.0) and FPED from 2011-2012 and will not be updated with future data releases.
Patent AT-E401277-T1: [Translated] DEVICE FOR EMPTYING A FLAT-BOTTOM SILO

The device (4) has a spiral brush (40) that is carried by a drive shaft (41) for being rotated around a horizontal axis. The device slides against an emptying device (3) for being rotated around a vertical axis. The brush due to its rotation intercepts and ejects a residual product volume towards a central bunker (102).
Compound 527197: 1',3,6-trimethylspiro[3,3a,4,5,6,7a-hexahydro-2H-1-benzofuran-7,3'-cyclopentene]

Chemical compound data from PubChem database. IUPAC Name: 1',3,6-trimethylspiro[3,3a,4,5,6,7a-hexahydro-2H-1-benzofuran-7,3'-cyclopentene]. Molecular Formula: C15H24O. Molecular Weight: 220.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Miami - Dade Div: Drug-Related Emergency Department Visits, 2004-2011 - All Misuse and Abuse

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving drug misuse or abuse in the Miami metropolitan area, Dade division, covering 2004-2011. Drug misuse/abuse visits include the use of illicit drugs, nonmedical use of pharmaceuticals, underage drinking and visits where alcohol was combined with another drug.
National Survey of Children in Nonparental Care

This survey provides nationally representative estimates on the characteristics, living arrangements, and service accessibility of noninstitutionalized children who were living apart from their parents (in foster care, grandparent care or other nonparental care) and who were aged 0 to 16 years in 2011-2012. Data on the well-being of the children and of their caregivers are also available. The children’s nonparental care status was identified in a previous SLAITS survey, the 2011-2012 National Survey of Children’s Health.

<b>Units of Response: </b>Caregiver

<b>Type of Data: </b>Survey

<b>Tribal Data: </b>No

<b>Periodicity: </b>One-time

<b>Demographic Indicators: </b>Disability;Ethnicity;Household Income;Household Size;Housing Status;Race;Sex

<b>SORN: </b>https://www.federalregister.gov/documents/2022/09/19/2022-20139/privacy-act-of-1974-system-of-records

<b>Data Use Agreement: </b>No

<b>Data Use Agreement Location: </b>Unavailable

<b>Granularity: </b>Household

<b>Spatial: </b>United States

<b>Geocoding: </b>Unavailable
Patent AT-E401152-T1: [Translated] METHOD AND DEVICE FOR DETECTING SLAG

The invention relates to a method and a device ot detecting the presence of slag in a shroud (4) through which molten metal passes from a ladle (2) to a tundish (6). A transmitting coil (20) generates an electromagnetic field. An induced voltage generated at a receiving coil (24) is compared with a defined voltage range. If the induced voltage has a value outside the defined voltage range it is indicative of the presence of slag. The coils (20, 24) are arranged in an unmovable manner in relation to the shroud. The invention also relates to a casting plant. <IMAGE>
Cre reporter strains produced by targeted insertion of

Background
          Several Cre reporter strains of mice have been described, in which a lacZ gene is turned on in cells expressing Cre recombinase, as well as their daughter cells, following Cre-mediated excision of a loxP-flanked transcriptional "stop" sequence. These mice are useful for cell lineage tracing experiments as well as for monitoring the expression of Cre transgenes. The green fluorescent protein (GFP) and variants such as EYFP and ECFP offer an advantage over lacZ as a reporter, in that they can be easily visualized without recourse to the vital substrates required to visualize β-gal in living tissue.
        
        
          Results
          In view of the general utility of targeting the ubiquitously expressed ROSA26 locus, we constructed a generic ROSA26 targeting vector. We then generated two reporter lines of mice by inserting EYFP or ECFP cDNAs into the ROSA26 locus, preceded by a loxP-flanked stop sequence. These strains were tested by crossing them with transgenic strains expressing Cre in a ubiquitous (β-actin-Cre) or a cell-specific (Isl1-Cre and En1-Cre) pattern. The resulting EYFP or ECFP expression patterns indicated that the reporter strains function as faithful monitors of Cre activity.
        
        
          Conclusions
          In contrast to existing lacZ reporter lines, where lacZ expression cannot easily be detected in living tissue, the EYFP and ECFP reporter strains are useful for monitoring the expression of Cre and tracing the lineage of these cells and their descendants in cultured embryos or organs. The non-overlapping emission spectra of EYFP and ECFP make them ideal for double labeling studies in living tissues.
2018 Uniform Reporting System (URS) Table for Federated States of Micronesia

This is the 2018 Uniform Reporting System (URS) Output Tables for Federated States of Micronesia. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528781: Cyclohexatriacontasiloxane, doheptacontamethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20,22,22,24,24,26,26,28,28,30,30,32,32,34,34,36,36,38,38,40,40,42,42,44,44,46,46,48,48,50,50,52,52,54,54,56,56,58,58,60,60,62,62,64,64,66,66,68,68,70,70,72,72-doheptacontamethyl-1,3,5,7,9,11,13,15,17,19,21,23,25,27,29,31,33,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67,69,71-hexatriacontaoxa-2,4,6,8,10,12,14,16,18,20,22,24,26,28,30,32,34,36,38,40,42,44,46,48,50,52,54,56,58,60,62,64,66,68,70,72-hexatriacontasilacyclodoheptacontane. Molecular Formula: C72H216O36Si36. Molecular Weight: 2669.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions

Treatment decisions related to disease prevention are often based on two conventional and related assumptions. First, an intervention-induced change in a surrogate marker (such as high-density lipoprotein [HDL]-cholesterol) in the desired direction translates into health benefits (such as reduction in coronary events). Second, it is unimportant which interventions are used to alter surrogate markers, since an intervention benefit is independent of the means by which it is achieved. The scientific foundation for these assumptions has been questioned. In this commentary, the appropriateness of relying on low levels of HDL-cholesterol for treatment decisions is reviewed. The Veterans Affairs - HDL-Cholesterol Intervention Trial (VA-HIT) investigators recently reported that only 23% of the gemfibrozil-induced relative reduction in risk of coronary events observed in the trial could be explained by changes in HDL-cholesterol between baseline and the 1-year visit. Thus, 77% of the health benefit to the participants was unexplained. Other possible explanations are that gemfibrozil has multiple mechanisms of action, disease manifestations are multifactorial, and laboratory measurements of HDL-cholesterol are imprecise. The wisdom of relying on levels and changes in surrogate markers such as HDL-cholesterol to make decisions about treatment choices should questioned. It seems better to rely on direct evidence of health benefits and to prescribe specific interventions that have been shown to reduce mortality and morbidity. Since extrapolations based on surrogate markers may not be in patients' best interest, the practice of medicine ought to be evidence-based.
Patent AT-E401690-T1: [Translated] AXIAL FLOW ELECTRIC MOTOR STAND

The stator has cores (3) rising along an axial direction (10) from a base (2) and are placed on the base in a circular manner, where each core receives a coil (4). Assembled parts (11, 12, 13) have interlocking surfaces, where some of the parts constituting partially the cores are made from a powder of compacted magnetic material. The interlocking surfaces are defined by a generator parallel to the axial direction.
Compound 525244: N''-(3-nitro-phenyl)-N,N,N',N'-tetramethyl-guanidine

Chemical compound data from PubChem database. IUPAC Name: 1,1,3,3-tetramethyl-2-(3-nitrophenyl)guanidine. Molecular Formula: C11H16N4O2. Molecular Weight: 236.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526606: 1,5-Anhydro-3,6-di-O-acetyl-2,4-di-O-methyl-D-glucitol

Chemical compound data from PubChem database. IUPAC Name: (4-acetyloxy-3,5-dimethoxyoxan-2-yl)methyl acetate. Molecular Formula: C12H20O7. Molecular Weight: 276.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2017 Methodological Summary and Definitions

This report is organized into seven sections. Section A describes the survey, including information about the sample design, data collection procedures, and key aspects of data processing (e.g., development of analysis weights). Section B presents technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, and issues for selected substance use and mental health measures. Section C discusses special topics related to prescription psychotherapeutic drugs. A glossary that covers key definitions used in NSDUH reports and tables is included in Section D. Section E describes other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population. A list of references cited in the report (Section F) and a list of contributors to this report (Section G) also are provided.